Skip to main content

Corbus Pharmaceuticals Holdings, Inc.

CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001595097

In the last 90 days, Corbus Pharmaceuticals Holdings, Inc. insiders filed 1 open-market purchase and 3 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $129.1M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Corbus Pharmaceuticals Holdings, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of CRBP: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders8783−4
Shares44.8M44.5M−252.3K (−0.6%)
Value$45.6M$27.2M−$18.4M (−40.3%)

New holders (14)

Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to CRBP in Q4 2021
InstitutionSharesValue% of portfolio
Renaissance Technologies LLC245,700$151.0K0.00%
Acadian Asset Management LLC184,026$112.0K0.00%
Two Sigma Securities, LLC45,997$28.0K0.01%
Spire Wealth Management45,000$28.0K0.00%
Engineers Gate Manager LP20,101$12.0K0.00%
Synovus Financial Corp16,000$10.0K0.00%
Parametric Portfolio Associates LLC10,596$7.00K0.00%
Two Sigma Advisers, LP11,300$7.00K0.00%
Cambridge Trust Co4,000$2.00K0.00%
CoreCap Advisors, LLC750$1.00K0.00%
CWM, LLC101$00.00%
Quadrant Capital Group LLC665$00.00%
Retirement Planning Co of New England, Inc.100$00.00%
KRS Capital Management, LLC11$00.00%

Sold out (18)

Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.